Resolution passed - 29 July 2013
Dechra Pharmaceuticals PLC
("Dechra" or the "Company")
Result of General Meeting
Proposed disposal of the Services Segment
29 July 2013
For immediate release
At a General Meeting of the Company held earlier today, the resolution to approve the proposed disposal of the entire issued share capital of National Veterinary Services Limited to Patterson Companies, Inc. (the "Disposal"), as set out in the Notice of General Meeting dated 11 July 2013, was duly passed. The trade, assets and liabilities (save for certain excluded liabilities) of the Services Segment that were owned by Dechra Limited were transferred into National Veterinary Services Limited on 5 July 2013 in order to facilitate the Disposal.
Issued Share Capital at meeting date: 87,157,444
Number of Shareholders in attendance: 11
The resolution was passed on a show of hands
Details of the proxy voting instructions lodged prior to the General Meeting are set out below:
|
Resolution |
Votes for (1) |
% |
Votes against |
% |
Votes withheld(2) |
|
To approve the proposed disposal of the entire issued share capital of National Veterinary Services Limited to Patterson Companies, Inc. |
69,181,153 |
99.95 |
32,476 |
0.05 |
734,589 |
Notes
(1) Includes discretionary votes
(2) A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution
(3) No votes were lodged in favour of a Third Party
(4) Votes tendered in respect of 69,213,629 shares representing 79.41% of the issued share capital
In accordance with Listing Rule 9.6.2, a copy of the resolution will shortly be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.
The full text of the resolution passed at the Meeting can be found in the Notice, which is available for inspection at www.morningstar.co.uk/uk/NSM and on the Company's website at www.dechra.com.
In addition to the passing of the above resolution, completion of the Disposal is conditional, inter alia, on the issue of certain regulatory licences in the name of National Veterinary Services Limited. The Company still expects the Disposal to complete by mid-August 2013.
|
Enquiries: |
|
|
Zoe Goulding, Company Secretary |
Fiona Tooley, Director |
|
Dechra Pharmaceuticals PLC |
TooleyStreet Communications |
|
Telephone: + 44 (0) 1606 814730 |
Telephone: +44 (0) 121 309 0099 |
|
www.dechra.com |
Mobile: +44 (0) 778 570 3523 (FT) |
|
|
Ticker: Full Listing (Pharmaceuticals): DPH |
About Dechra
Dechra is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS
Latest directors dealings
- 5 hours ago Luceco
- 5 hours ago Helios Towers
- 6 hours ago Wise Class A
- 6 hours ago EDX Medical Group Plc
- 6 hours ago Naked Wines